Medallion Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,014
Closed -$1.96M 1270
2026
Q1
$1.96M Buy
8,014
+1,033
+15% +$241K 0.64% 36
2025
Q4
$1.44M Buy
6,981
+475
+7% +$93.9K 0.49% 54
2025
Q3
$1.21M Buy
6,506
+18
+0.3% +$3.08K 0.43% 56
2025
Q2
$1.01M Buy
6,488
+319
+5% +$49K 0.39% 65
2025
Q1
$971K Buy
6,169
+274
+5% +$42.9K 0.44% 51
2024
Q4
$896K Buy
+5,895
New +$914K 0.44% 52

Other funds holding JNJ

Medallion Wealth Advisors's JNJ Position: Q2 2026 in Review

Medallion Wealth Advisors sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 8,014 shares — an estimated $1.96M sold.

Medallion Wealth Advisors first reported a position in JNJ in Q4 2024 and held it in 6 quarters. The position peaked at $1.96M in Q1 2026. 4,689 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Medallion Wealth Advisors reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • Medallion Wealth Advisors sold 8,014 Johnson & Johnson shares in Q2 2026, an estimated $1.96M.
  • Medallion Wealth Advisors first reported a position in Johnson & Johnson in Q4 2024 and held it in 6 quarters.
  • Medallion Wealth Advisors's Johnson & Johnson position peaked at $1.96M in Q1 2026.
  • 4,689 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Medallion Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.